Mr Thomas Andrew Cummings, MSW | |
41 Scott Ln, None, Windsor, CT 06095-2440 | |
(860) 687-1105 | |
(860) 687-1105 |
Full Name | Mr Thomas Andrew Cummings |
---|---|
Gender | Male |
Speciality | Counselor - Mental Health |
Location | 41 Scott Ln, Windsor, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346305745 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Thomas Andrew Cummings, MSW 41 Scott Ln, None, Windsor, CT 06095-2440 Ph: (860) 687-1105 | Mr Thomas Andrew Cummings, MSW 41 Scott Ln, None, Windsor, CT 06095-2440 Ph: (860) 687-1105 |
News Archive
Bring the drugs, hold the suds. That summarizes a promising new drug-making technique designed to reduce serious allergic reactions and other side effects from anti-cancer medicine, testosterone and other drugs that are administered with a needle.
Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.
African American men are more likely to develop prostate cancer than European American men, and are also more than twice as likely to die from it. Although there are many reasons that contribute to this health disparity, new research shows that African American men may have a distinctly different type of prostate cancer than European American men, according to new genomic fingerprinting results.
AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.
The American College of Physicians (ACP) is pleased to announce that ACP Internist, ACP Hospitalist, and ACP InternistWeekly have won awards for excellence in publishing.
› Verified 4 days ago
Brittany Bauer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 995 Day Hill Rd, Windsor, CT 06095 Phone: 860-697-3351 Fax: 860-731-5536 | |
Destiny Grant, Counselor Medicare: Not Enrolled in Medicare Practice Location: 995 Day Hill Rd, Windsor, CT 06095 Phone: 860-731-5522 Fax: 860-731-5536 | |
Joyce A Erickson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1343 Hillside Cir, Windsor, CT 06095 Phone: 860-707-9438 | |
Nardine Staroverov, Counselor Medicare: Not Enrolled in Medicare Practice Location: 32 Maple Ave Ste C, Windsor, CT 06095 Phone: 860-593-4908 | |
Valerie Barrett-noel, Counselor Medicare: Medicare Enrolled Practice Location: 600 W Wolcott Ave, Windsor, CT 06095 Phone: 860-794-0652 | |
Antonette Bailey, Counselor Medicare: Not Enrolled in Medicare Practice Location: 995 Day Hill Rd, Windsor, CT 06095 Phone: 860-731-5522 Fax: 860-731-5536 | |
Mrs. Rosanna Z Wilson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Kellogg St, Windsor, CT 06095 Phone: 860-219-1029 |